Subcontract to Tekmira: Dose Response Efficacy Study of TKM-100201 for the Treatment of Ebola Virus in Rhesus Macaques

Project: Other project

Project Details

StatusFinished
Effective start/end date1/15/12 → 12/31/12

Funding

  • Tekmira Pharmaceuticals Corporation: $235,335.00